Garnet BioTherapeutics is a clinical stage regenerative medicine company based in Malvern, PA that is targeting the acceleration of healing and reduced scarring associated with surgical procedures and other dermatologic conditions.
Garnet BioTherapeutics has identified a distinct population of bone marrow derived cells capable of reducing inflammation and promoting healing. In addition, the company has developed proprietary scalable cell expansion technology that can generate a large number of patient doses from a single source. When used topically on the skin or administered internally, these cells release anti-inflammatory and pro-healing factors that accelerate healing and reduce scarring.
The Company is initially developing its cell-based therapy for cosmetic and dermatologic applications where accelerated healing and reduced scarring are desirable. Cosmetic applications – such as liposuction, breast augmentation, abdominoplasty and facelifts – represent an addressable market opportunity of more than $1 billion worldwide. Plastic surgeons often cite scarring as a top patient concern in cosmetic surgical procedures. Garnet BioTherapeutics believes that the cell-based therapy may also be applicable in burns, auto-immune disorders such as psoriasis, and in other conditions where inflammation or scar formation plays an important role in disease pathology.
Website:
www.garnetbio.com
Partner Company Since 2008